| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers S > Headlines for Savient Pharmaceuticals, Inc. > News item |
Savient Pharmaceuticals records $2.92 million net loss for November
By Caroline Salls
Pittsburgh, Dec. 20 - Savient Pharmaceuticals, Inc. reported a $2.92 million net loss for November on $1.65 million of net revenue, according to its monthly operating report filed Friday with the U.S. Bankruptcy Court for the District of Delaware.
In comparison, Savient posted a $9.79 million net loss for the period of Oct. 15 to Oct. 31 on $1.57 million of net revenue.
The company had $15.9 million of cash and cash equivalents as of Nov. 30, up from $14.28 million at the end of October.
Savient, an East Brunswick, N.J., pharmaceutical company, filed for bankruptcy on Oct. 15 in the U.S. Bankruptcy Court for the District of Delaware. The Chapter 11 case number is 13-12680.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.